Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage

Yulan Cheng, Ana P. Kiess, Joseph M. Herman, Martin G. Pomper, Stephen J. Meltzer, John M. Abraham

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phosphorus-32, a clinically available drug, inhibits cancer growth by inducing DNA double-strand breakage'. Together they form a unique fingerprint.

Agriculture & Biology

Medicine & Life Sciences

Chemical Compounds